Literature DB >> 8358236

Deficiency of dystrophin-associated proteins: a common mechanism leading to muscle cell necrosis in severe childhood muscular dystrophies.

K Matsumura1, K P Campbell.   

Abstract

Dystrophin is a large cytoskeletal protein encoded by the Duchenne muscular dystrophy (DMD) gene. Dystrophin is associated with a large oligomeric complex of sarcolemmal glycoproteins, including the novel laminin-binding glycoprotein called dystroglycan, which provides a linkage to the extracellular matrix. In DMD, the absence of dystrophin leads to a drastic reduction in all of the dystrophin-associated proteins. In severe childhood autosomal recessive muscular dystrophy with DMD-like phenotype (SCARMD), a specific deficiency of the 50 kDa dystrophin-associated glycoprotein is found. Thus, the disruption/dysfunction of the dystrophin-glycoprotein complex due to the deficiency of one or more of the dystrophin-associated proteins is presumed to cause the disruption of the linkage between the subsarcolemmal cytoskeleton and the extracellular matrix. This may render muscle cells susceptible to necrosis in two forms of severe childhood muscular dystrophy, DMD and SCARMD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358236     DOI: 10.1016/0960-8966(93)90002-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  15 in total

1.  Convergent regulation of skeletal muscle Ca2+ channels by dystrophin, the actin cytoskeleton, and cAMP-dependent protein kinase.

Authors:  Barry D Johnson; Todd Scheuer; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

2.  Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.

Authors:  Karim Hnia; Gerald Hugon; François Rivier; Ahmed Masmoudi; Jacques Mercier; Dominique Mornet
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  A patch-clamp study of delayed rectifier currents in skeletal muscle of control and mdx mice.

Authors:  S D Hocherman; F Bezanilla
Journal:  J Physiol       Date:  1996-05-15       Impact factor: 5.182

Review 4.  Recent advances in muscular dystrophies and myopathies.

Authors:  J R Anderson
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

Review 5.  Cell death, clearance and immunity in the skeletal muscle.

Authors:  C Sciorati; E Rigamonti; A A Manfredi; P Rovere-Querini
Journal:  Cell Death Differ       Date:  2016-02-12       Impact factor: 15.828

6.  The mitochondrial permeability transition pore and the cardiac necrotic program.

Authors:  Christopher P Baines
Journal:  Pediatr Cardiol       Date:  2011-01-06       Impact factor: 1.655

7.  Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry.

Authors:  R Herrmann; V Straub; K Meyer; T Kahn; M Wagner; T Voit
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

8.  Molecular and functional analysis of the utrophin promoter.

Authors:  C L Dennis; J M Tinsley; A E Deconinck; K E Davies
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

9.  Intracellular Ca2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres.

Authors:  J Pressmar; H Brinkmeier; M J Seewald; T Naumann; R Rüdel
Journal:  Pflugers Arch       Date:  1994-04       Impact factor: 3.657

10.  Immunogold localization of the 43-kDa dystroglycan at the plasma membrane in control and dystrophic human muscle.

Authors:  M J Cullen; J Walsh; L V Nicholson
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.